Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by shareswapperon Feb 23, 2020 3:17pm
101 Views
Post# 30723096

RE:Make it reach .09 and I am out

RE:Make it reach .09 and I am outGoose, I think you'd be selling yourself short at $.09  This past week the stock was taken down by a single investor and people are wondering why?  Our Phase 1B study is a safety and tolerability study of 100 and 400mg doses.  In the previous Phase 1 Study we tested safety and tolerability in 32 Patients at 100, 200, 400 and 800mg and showed no adverse events at even the highest dose.  So the chances of the Phase 1B coming back as unsafe are pretty low.  So why did the share price tank? My guess is the opposite, the results are positive so we will be proceeding immediately to an 80 person Phase II efficacy study in April.  Of course this kind of stdy will cost at a minimum a couple million $$$ so we are undoubtedly looking at a financing in March to pay for it.  Someone has obviously causght wind and is unloading to participate in the offering.  Just my speculation of course, we will know in time how this all plays out.  Pending updates soon, I suspect we get Phase 1B results this week or next at the latest.  Good luck Longs!!
<< Previous
Bullboard Posts
Next >>